We also analyzed the percentage of lymphocyte subsets (CD4+, CD8+ and CD19+) expressing surface and/of intracellular CTLA-4 in cancer patients and healthy volunteers, aiming to figure out the correlation between lymphocytes CTLA4 locations and their susceptibility to cancers. This evidence concerns the gene CD4 and cancer.